Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Therapeutic Agents: Other Topics: Poster Presentations - Proffered Abstracts

  • Abstract LB-B28: Abietane natural products as novel therapeutics against solid tumors
    Walter Lang, Taotao Ling, Jangsoon Lee, Naoto T. Ueno, Fatima Rivas
    Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) LB-B28; DOI: 10.1158/1535-7163.TARG-17-LB-B28
  • Abstract B139: Promising antitumor effects of SNX-5422 in combination with checkpoint inhibitors in an MC38 murine model
    Yanmei Sun, Xirou Hu, Everardus Orlemans
    Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) B139; DOI: 10.1158/1535-7163.TARG-17-B139
  • Abstract B123: A mesenchymal subset of cancers with elevated ZEB1 expression is sensitive to low doses of silver nanoparticles
    Cale D. Fahrenholtz, Jessica Swanner, James Sears, Katherine Cook, Pierre-Alexandre Vidi, Ravi Singh
    Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) B123; DOI: 10.1158/1535-7163.TARG-17-B123
  • Abstract B129: Development and preclinical assessment of a first-in-class small-molecule inhibitor of FLIP
    Catherine A. Higgins, Joanna Majkut, Jennifer Fox, Luke Humphreys, Greti Espona Fiedler, Ray J. Boffey, Trevor R. Perrior, David Haigh, Timothy Harrison, Daniel B. Longley
    Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) B129; DOI: 10.1158/1535-7163.TARG-17-B129
  • Abstract B126: AG-881, a brain penetrant, potent, pan-mutant IDH (mIDH) inhibitor for use in mIDH solid and hematologic malignancies
    Katharine Yen, Zenon Konteatis, Zhihua Sui, Erin Artin, Lenny Dang, Kimberly Straley, Erica Tobin, Carl Campos, Hua Yang, Raj Nagaraja, Yue Chen, Hyeryun Kim, Camelia Gliser, Brandon Nicolay, Andrew Olaharski, Lee Silverman, Scott Biller, Shinsan M. Su, Ingo Mellinghoff, Janeta Popovici-Muller
    Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) B126; DOI: 10.1158/1535-7163.TARG-17-B126
  • Abstract B138: Prognostic value of PTEN loss for second-line paclitaxel treatment efficacy in metastatic gastric cancer
    Kyoo Hyun Kim, Jeong Hyun Jo, Sejung Park, Minkyu Jung, Woo Sun Kwon, Jee Hung Kim, Hyo Song Kim, Seung-Hoon Beom, Hyun Cheol Chung, Sun Young Rha
    Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) B138; DOI: 10.1158/1535-7163.TARG-17-B138
  • Abstract B135: The mechanism of action of BT1718, a novel small-molecule drug conjugate for the treatment of solid tumors expressing MT1-MMP
    Gavin Bennett, Mike Rigby, Bob Lutz, Peter Park, Nicholas Keen
    Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) B135; DOI: 10.1158/1535-7163.TARG-17-B135
  • Abstract B141: Repurposing of ketorolac for the treatment of renal cell carcinoma (RCC)
    Jeevan Deepak Ghosalkar, Siddhika Rajiv Raut, Mariamma Charles Thekkumpurath, Geena Malhotra, Kalpana Sanjay Joshi
    Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) B141; DOI: 10.1158/1535-7163.TARG-17-B141
  • Abstract B130: Differentiated pharmacology of the imipridone ONC201: the first selective DRD2/3 antagonist in clinical oncology
    Neel S. Madhukar, Varun Vijay Prabhu, Lakshmi Anantharaman, Chidananda Sulli, Edgar Davidson, Sean Deacon, Joseph Rucker, Neil Charter, Benjamin Doranz, Wolfgang Oster, Olivier Elemento, R. Benjamin Free, David Sibley, Joshua E. Allen
    Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) B130; DOI: 10.1158/1535-7163.TARG-17-B130
  • Abstract B143: The formation of redox active complexes is important for the induction of the UPR by Dp44mT
    Angelica Merlot, Nurul Shafie, Georgia Porter, Sumit Sahni, Des Richardson
    Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) B143; DOI: 10.1158/1535-7163.TARG-17-B143

Pages

  • Next
  • 1
  • 2
  • 3
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement